These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17192765)

  • 1. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
    Beal MF
    Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 in neurodegenerative diseases.
    Shults CW
    Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR; Cudkowicz ME
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
    Beal MF
    Free Radic Res; 2002 Apr; 36(4):455-60. PubMed ID: 12069110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
    Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
    Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang LN; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
    Beal MF; Matthews RT
    Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
    Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 in neuromuscular and neurodegenerative disorders.
    Mancuso M; Orsucci D; Volpi L; Calsolaro V; Siciliano G
    Curr Drug Targets; 2010 Jan; 11(1):111-21. PubMed ID: 20017723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
    Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL
    Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway.
    Choi H; Park HH; Koh SH; Choi NY; Yu HJ; Park J; Lee YJ; Lee KY
    Neurotoxicology; 2012 Jan; 33(1):85-90. PubMed ID: 22186599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants, supplements, and Parkinson's disease.
    Weber CA; Ernst ME
    Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Avcı B; Günaydın C; Güvenç T; Yavuz CK; Kuruca N; Bilge SS
    Neurochem Res; 2021 Mar; 46(3):513-522. PubMed ID: 33247801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.